Cargando…

Polymorphisms in CLDN1 are associated with age and differentiation of triple-negative breast cancer patients

Purpose: Triple-negative breast cancer (TNBC) is a highly heterogeneous disease. It is very important to explore novel biomarkers to better clarify the characteristics of TNBC. It has been reported that polymorphisms in claudin 1 (CLDN1) are associated with risk of several cancers. But till now, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Aimin, Li, Junyu, Ruan, Shufang, Fan, Ying, Liao, Yuqian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481238/ https://www.ncbi.nlm.nih.gov/pubmed/30910845 http://dx.doi.org/10.1042/BSR20181952

Ejemplares similares

Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy
por: Liao, Yuqian, et al.
Publicado: (2018)

A CLDN1-Negative Phenotype Predicts Poor Prognosis in Triple-Negative Breast Cancer
por: Ma, Fei, et al.
Publicado: (2014)

CLDN1 Sensitizes Triple-Negative Breast Cancer Cells to Chemotherapy
por: Lemesle, Marine, et al.
Publicado: (2022)

Polymorphisms in PARP1 predict disease-free survival of triple-negative breast cancer patients treated with anthracycline/taxane based adjuvant chemotherapy
por: Liao, Yuqian, et al.
Publicado: (2020)

Polymorphism of the CLDN5 gene and Schizophrenia in an Iranian Population
por: OMIDINIA, Eskandar, et al.
Publicado: (2014)

CLDN10 single nucleotide polymorphism rs1325774 alters the risk of breast cancer in south chinese women
por: Liao, Jinling, et al.
Publicado: (2018)

Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications
por: Kwon, Mi Jeong, et al.
Publicado: (2010)

Association of CLDN6 and CLDN10 With Immune Microenvironment in Ovarian Cancer: A Study of the Claudin Family
por: Gao, Peipei, et al.
Publicado: (2021)

CLDN6 promotes chemoresistance through GSTP1 in human breast cancer
por: Yang, Minlan, et al.
Publicado: (2017)

Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma
por: Zhang, Zhenfa, et al.
Publicado: (2013)

LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer
por: Lv, Mingming, et al.
Publicado: (2016)

Mutations in CLDN14 are associated with different hearing thresholds
por: Bashir, Rasheeda, et al.
Publicado: (2010)

CLDN10 is Associated with Papillary Thyroid Cancer Progression
por: Zhou, Yili, et al.
Publicado: (2018)

Analysis of single-nucleotide polymorphisms in genes associated with triple-negative breast cancer
por: G., Vigneshwaran, et al.
Publicado: (2022)

The Expression of CLDN6 in Hepatocellular Carcinoma Tissue and the Effects of CLDN6 on Biological Phenotypes of Hepatocellular Carcinoma Cells
por: Lu, Yan, et al.
Publicado: (2021)

Applicability of Anticancer Drugs for the Triple-Negative Breast Cancer Based on Homologous Recombination Repair Deficiency
por: Liao, Gaoming, et al.
Publicado: (2022)

SMAD2 Inactivation Inhibits CLDN6 Methylation to Suppress Migration and Invasion of Breast Cancer Cells
por: Lu, Yan, et al.
Publicado: (2017)

Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer
por: Chen, Bo, et al.
Publicado: (2018)

Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
por: Swanner, Jessica, et al.
Publicado: (2015)

Association of the Telomerase Reverse Transcriptase rs10069690 Polymorphism with the Risk, Age at Onset and Prognosis of Triple Negative Breast Cancer
por: Zins, Karin, et al.
Publicado: (2023)

The IL1β-HER2-CLDN18/CLDN4 axis mediates lung barrier damage in ARDS
por: Ma, Xinhua, et al.
Publicado: (2020)

Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
por: McDermott, Martina S.J., et al.
Publicado: (2023)

Association study of CLDN14 variations in patients with kidney stones
por: Ullah, Ihsan, et al.
Publicado: (2022)

A SUMOylation-dependent HIF-1α/CLDN6 negative feedback mitigates hypoxia-induced breast cancer metastasis
por: Jia, Yiyang, et al.
Publicado: (2020)

Analysis of the expression and genetic alteration of CLDN18 in gastric cancer
por: Li, Jian, et al.
Publicado: (2020)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

A Common Variant in CLDN14 is Associated with Primary Biliary Cirrhosis and Bone Mineral Density
por: Tang, Ruqi, et al.
Publicado: (2016)

Mammography and ultrasound effective features in differentiating basal-like and normal-like subtypes of triple negative breast cancer
por: Zeng, Zeng, et al.
Publicado: (2017)

CLDN4 as a Novel Diagnostic and Prognostic Biomarker and Its Association with Immune Infiltrates in Ovarian Cancer
por: Hu, Pan, et al.
Publicado: (2023)

Comprehensive Analysis of the Implication of PGRMC1 in Triple-Negative Breast Cancer
por: Xu, Xin, et al.
Publicado: (2021)

There Is No Association between MicroRNA Gene Polymorphisms and Risk of Triple Negative Breast Cancer in a Chinese Han Population
por: Ma, Fei, et al.
Publicado: (2013)

CLDN3 expression and function in pregnancy-induced hypertension
por: Zhao, Aixin, et al.
Publicado: (2020)

CLDN1 regulates trophoblast apoptosis and proliferation in preeclampsia
por: Zhang, Yu-chen, et al.
Publicado: (2021)

CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation
por: Gao, Jing, et al.
Publicado: (2023)

Membranous and nuclear staining of CLDN18 in HPV‐independent and HPV‐associated endocervical adenocarcinomas
por: Du, Xiuzhen, et al.
Publicado: (2022)

Up-regulation of CLDN1 in gastric cancer is correlated with reduced survival
por: Eftang, Lars L, et al.
Publicado: (2013)

Tumour Necrosis Factor-α Gene Polymorphism Is Associated with Metastasis in Patients with Triple Negative Breast Cancer
por: Li, Hui-Hui, et al.
Publicado: (2015)

Salicylate •Phenanthroline copper (II) complex induces apoptosis in triple-negative breast cancer cells
por: Fan, Limei, et al.
Publicado: (2017)

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_6f44ntsfav5jm8qggtqqjurcbg